Opportunity ID: 340880

General Information

Document Type: Grants Notice
Funding Opportunity Number: PA-22-176
Funding Opportunity Title: PHS 2022-2 Omnibus Solicitation of the NIH, CDC and FDA for Small Business Innovation Research Grant Applications (Parent SBIR [R43/R44] Clinical Trial Not Allowed)
Opportunity Category: Discretionary
Opportunity Category Explanation:
Funding Instrument Type: Grant
Category of Funding Activity: Education
Environment
Food and Nutrition
Health
Income Security and Social Services
Category Explanation:
Expected Number of Awards:
Assistance Listings: 93.068 — Chronic Diseases: Research, Control, and Prevention
Cost Sharing or Matching Requirement: No
Version: Synopsis 1
Posted Date: Jun 02, 2022
Last Updated Date: Jun 02, 2022
Original Closing Date for Applications: Apr 05, 2023
Current Closing Date for Applications: Apr 05, 2023
Archive Date: May 11, 2023
Estimated Total Program Funding:
Award Ceiling: $275,766
Award Floor:

Eligibility

Eligible Applicants: Small businesses
Additional Information on Eligibility: Other Eligible Applicants include the following: Non-domestic (non-U.S.) Entities (Foreign Institutions) are not eligible to apply. Non-domestic (non-U.S.) components of U.S. Organizations are not eligible to apply. Foreign components, as defined in the NIH Grants Policy Statement, may be allowed.

Additional Information

Agency Name: National Institutes of Health
Description: This Funding Opportunity Announcement (FOA), issued by the National Institutes of Health (NIH), the Centers for Disease Control and Prevention (CDC), and the Food and Drug Administration (FDA), invites eligible United States small businesses to submit Small Business Innovation Research (SBIR) grant applications. United States small businesses that have the research capabilities and technological expertise to contribute to the R and D mission(s) of the NIH, CDC, and FDA awarding components identified in this FOA are encouraged to submit SBIR grant applications in response to identified topics (see PHS 2022-2 SBIR/STTR Program Descriptions and Research Topics for NIH, CDC, and FDA. This Parent Funding Opportunity Announcement does not accept clinical trials.
Link to Additional Information: http://grants.nih.gov/grants/guide/pa-files/PA-22-176.html
Grantor Contact Information: If you have difficulty accessing the full announcement electronically, please contact:

NIH OER Webmaster
OERWebmaster03@od.nih.gov
Email:OERWebmaster03@od.nih.gov

Version History

Version Modification Description Updated Date

Folder 340880 Full Announcement-PA-22-176 -> PA-22-176-Full-Announcement.pdf

Packages

Agency Contact Information: NIH OER Webmaster
OERWebmaster03@od.nih.gov
Email: OERWebmaster03@od.nih.gov
Who Can Apply: Organization Applicants

Assistance Listing Number Competition ID Competition Title Opportunity Package ID Opening Date Closing Date Actions
FORMS-G Use for due dates on or before January 24, 2023 PKG00274777 Aug 05, 2022 Jan 24, 2023 View
FORMS-H Use for due dates on or after January 25, 2023 PKG00277441 Oct 26, 2022 Apr 05, 2023 View

Package 1

Mandatory forms

340880 RR_SF424_5_0-5.0.pdf

340880 PHS398_CoverPageSupplement_5_0-5.0.pdf

340880 RR_OtherProjectInfo_1_4-1.4.pdf

340880 PerformanceSite_4_0-4.0.pdf

340880 RR_KeyPersonExpanded_4_0-4.0.pdf

340880 RR_Budget_3_0-3.0.pdf

340880 PHS398_ResearchPlan_4_0-4.0.pdf

340880 SBIR_STTR_Information_3_0-3.0.pdf

340880 PHSHumanSubjectsAndClinicalTrialsInfo_3_0-3.0.pdf

Optional forms

340880 RR_SubawardBudget30_3_0-3.0.pdf

340880 PHS_AssignmentRequestForm_3_0-3.0.pdf

Package 2

Mandatory forms

340880 RR_SF424_5_0-5.0.pdf

340880 PHS398_CoverPageSupplement_5_0-5.0.pdf

340880 RR_OtherProjectInfo_1_4-1.4.pdf

340880 PerformanceSite_4_0-4.0.pdf

340880 RR_KeyPersonExpanded_4_0-4.0.pdf

340880 RR_Budget_3_0-3.0.pdf

340880 PHS398_ResearchPlan_5_0-5.0.pdf

340880 SBIR_STTR_Information_3_0-3.0.pdf

340880 PHSHumanSubjectsAndClinicalTrialsInfo_3_0-3.0.pdf

Optional forms

340880 RR_SubawardBudget30_3_0-3.0.pdf

340880 PHS_AssignmentRequestForm_3_0-3.0.pdf

2025-07-13T08:03:07-05:00

Share This Post, Choose Your Platform!

About the Author: